An experimental drug disables deadly botulism toxin much better than current treatment does, researchers report. They also suggest that the drug could be mass-produced and stockpiled as a deterrent to the use of botulism toxin, or botulin, as a weapon.
Scientists in recent years have identified antibodies that people and animals make when exposed to botulin or a botulism vaccine.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.